Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mucinous Adenocarcinoma of the Rectum”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT01814501
What this trial is testing

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+5 more
John Hays 16
Early research (Phase 1)Ended earlyNCT01285102
What this trial is testing

Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
Fox Chase Cancer Center 4
Not applicableStudy completedNCT02132858
What this trial is testing

Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

Who this might be right for
Mucinous Adenocarcinoma of the RectumRecurrent Rectal CancerSignet Ring Adenocarcinoma of the Rectum+6 more
Fox Chase Cancer Center 43
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Early research (Phase 1)Study completedNCT00060411
What this trial is testing

A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00745134
What this trial is testing

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+6 more
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)UnknownNCT00002896
What this trial is testing

Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer

Who this might be right for
Colorectal Cancer
European Institute of Oncology 774
Very early researchWithdrawnNCT01403103
What this trial is testing

Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01652196
What this trial is testing

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
John Hays 56
Testing effectiveness (Phase 2)Ended earlyNCT00052585
What this trial is testing

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumMucinous Adenocarcinoma of the Colon+7 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT02232152
What this trial is testing

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
Wake Forest University Health Sciences 19
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)UnknownNCT01037049
What this trial is testing

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Who this might be right for
Adenocarcinoma of the RectumAdenocarcinomaAdenocarcinoma, Mucinous+14 more
Royal Marsden NHS Foundation Trust 237
Early research (Phase 1)Study completedNCT02270606
What this trial is testing

Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the RectumRecurrent Rectal CancerSignet Ring Adenocarcinoma of the Rectum+7 more
Virginia Commonwealth University 14
Testing effectiveness (Phase 2)Study completedNCT00100841
What this trial is testing

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

Who this might be right for
Adenocarcinoma of the RectumMucinous Adenocarcinoma of the ColonRecurrent Colon Cancer+4 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Ended earlyNCT01197664
What this trial is testing

Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery

Who this might be right for
Mucinous Adenocarcinoma of the RectumStage IIA Rectal CancerStage IIB Rectal Cancer+3 more
Wake Forest University Health Sciences 2
Testing effectiveness (Phase 2)Study completedNCT01079780
What this trial is testing

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 136
Testing effectiveness (Phase 2)UnknownNCT01871571
What this trial is testing

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the RectumStage IIA Rectal Cancer+5 more
University of Southern California 17
Large-scale testing (Phase 3)Study completedNCT00005036
What this trial is testing

Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
National Cancer Institute (NCI) 560
Early research (Phase 1)Ended earlyNCT01198535
What this trial is testing

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+7 more
National Cancer Institute (NCI) 60
Load More Results